Page last updated: 2024-10-26

erythrosine and Leukemia, Myelomonocytic, Acute

erythrosine has been researched along with Leukemia, Myelomonocytic, Acute in 1 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Leukemia, Myelomonocytic, Acute: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.

Research Excerpts

ExcerptRelevanceReference
" Quantitative dose-response values obtained from surviving cell fractions assayed by flow cytometry at 24 h following drug exposure demonstrated the utility of this assay for quantitating drug-induced cytotoxic effects on primary human AML cells in short-term culture."1.29Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysis. ( Edelstein, MB; KuKuruga, MA; Media, JE; Nakeff, A; Valeriote, F, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakeff, A1
KuKuruga, MA1
Media, JE1
Valeriote, F1
Edelstein, MB1

Other Studies

1 other study available for erythrosine and Leukemia, Myelomonocytic, Acute

ArticleYear
Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysis.
    Journal of experimental therapeutics & oncology, 1996, Volume: 1, Issue:6

    Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Cell Count; Cell Line; Cell Survival; Flow Cytome

1996